Emerging infectious diseases
-
Emerging Infect. Dis. · Aug 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Potential, Iran, 2020.
To determine the transmission potential of severe acute respiratory syndrome coronavirus 2 in Iran in 2020, we estimated the reproduction number as 4.4 (95% CI 3.9-4.9) by using a generalized growth model and 3.5 (95% CI 1.3-8.1) by using epidemic doubling time. The reproduction number decreased to 1.55 after social distancing interventions were implemented.
-
Emerging Infect. Dis. · Aug 2020
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany.
During a meeting in Munich, Germany, a presymptomatic attendee with severe acute respiratory syndrome coronavirus 2 infected at least 11 of 13 other participants. Although 5 participants had no or mild symptoms, 6 had typical coronavirus disease, without dyspnea. Our findings suggest hand shaking and face-to-face contact as possible modes of transmission.
-
Emerging Infect. Dis. · Aug 2020
Case ReportsCOVID-19 and Acute Pulmonary Embolism in Postpartum Patient.
We report a 36-year-old woman in Iran who sought care for left shoulder pain and cough 5 days after a scheduled cesarean section. Acute pulmonary embolism and coronavirus disease were diagnosed. Physicians should be aware of the potential for these concurrent conditions in postpartum women.
-
Emerging Infect. Dis. · Aug 2020
Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China.
We explored the secondary attack rate in different types of contact with persons presymptomatic for coronavirus disease (COVID-19). Close contacts who lived with or had frequent contact with an index case-patient had a higher risk for COVID-19. Our findings provide population-based evidence for transmission from persons with presymptomatic COVID-19 infections.
-
We ran a simulation comparing 3 methods to calculate case-fatality risk for coronavirus disease using parameters described in previous studies. Case-fatality risk calculated from these methods all are biased at the early stage of the epidemic. When comparing real-time case-fatality risk, the current trajectory of the epidemic should be considered.